ArticleCell death & disease2026

HOXC9 accelerates esophageal squamous cell carcinoma progression via OTUD1-FABP5-mediated lipid metabolic reprogramming.

Cai Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.